Posted by Michael Wonder on 24 Jul 2018
Eli Lilly opposes using imports to tackle high drug prices
24 July 2018 - Major drug maker Eli Lilly denounced imports from overseas to provide competition for extremely high-priced drugs.
Lilly’s comments on Tuesday during an earnings call comes nearly a week after the Trump administration said it plans to examine using foreign imports to fight high prices. Lilly said the method itself was concerning.
“We think that is the wrong road to go down,” said Lilly CEO David Ricks on the call. “We agree it should be solved, [it’s] the method we disagree with.”
